VivoSim Labs, Inc.
VIVS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $4 | $3 | $3 |
| - Cash | $7 | $9 | $11 | $1 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | – | -$5 | -$8 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -24.3% | -27.5% | 112.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 91.7% |
| EBITDA | -$2 | -$3 | $7 | -$3 |
| % Margin | -8,871.4% | -7,508.1% | 13,564.7% | -14,062.5% |
| Net Income | -$3 | -$3 | $7 | -$3 |
| % Margin | -9,089.3% | -7,683.8% | 13,435.3% | -14,362.5% |
| EPS Diluted | -1.74 | -1.94 | 4.68 | -2.28 |
| % Growth | 10.3% | -141.5% | 305.3% | – |
| Operating Cash Flow | – | -$4 | -$2 | -$2 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$4 | -$2 | -$2 |